ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryIndustryMedical Technology IndustryZurichQvanteq AG
Qvanteq AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The core activity of Qvanteq AG is the development of biofunctional surfaces for medical devices and vascular stents, particularly with the goal of reducing thrombogenic effects and accelerating healing. The company focuses on developing technologies that prevent the activation of the blood coagulation cascade, thereby minimizing complications from medical devices and stents.

AI-generated
Offering

Products & services

Industry:Medical Technology Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Qvanteq AG

✓ Offered8
Qstent technology
Bio-based surface technology for vascular medical devices with antithrombotic properties, reduced inflammatory response and rapid endothelialisation; coating-free and suitable for various implants.
Coronary stents (Qstent Coronary Stent System)
Coronary stent systems in various length and diameter combinations with Qstent surface technology; developed for reduced neointimal hyperplasia and improved endothelialisation.
Neurovascular stents, coils and flow diverters
Surface technology for intracranial stents, coils and flow diverters made of Nitinol and CoCr for the treatment of intracranial aneurysms.
Peripheral stents
Qstent technology for self-expanding, Nitinol-based peripheral stents for the treatment of occluded peripheral arteries or veins.
Other medical devices
Surface technologies for pumps, implants and accessories beyond stent-like devices; antithrombotic for materials or combined medical devices.
Consulting and development services
Support for development programmes and consulting mandates, including quality, Regulatory/MDR, validation, manufacturing, engineering, project management and regulatory approval planning.
In vitro thrombogenicity testing
Conducting and supporting thrombogenicity assessments of new materials, surfaces or complete devices using whole human blood and endothelial cell models.
Medical device development
Development and development support for medical devices, including planning and conducting animal studies as well as support for regulatory approval.
Trust & reputation

ranQ Trust Score of Qvanteq AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

Qvanteq AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Qvanteq AG scores 85.5 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.100.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
Qvanteq AG scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Qvanteq AG scores 4.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.4.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Qvanteq AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Qvanteq AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Qvanteq AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Qvanteq AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Qvanteq AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hier entsteht die Karte
Technoparkstrasse 1
8005 Zurich

At a glance

Legal form
Corporation
UID
CHE-114.666.128
Founded
2009 · 17 years
Last commercial register change
December 9, 2025
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    JS
    JOTEC sales GmbH
    Zurich
    PS
    PerkinElmer Scientific (Switzerland) GmbH
    Bülach
    IA
    InSphero AG
    Schlieren
    MA
    Medyria AG
    Winterthur
    VS
    VP Sana Group AG
    Zurich
    SM
    Schnell Medical Switzerland GmbH
    Wädenswil
    SM
    Schnell Medical AG
    Wädenswil
    PM
    Polymed Medical Center AG
    Glattbrugg